Our technically qualified team of patent and trade mark attorneys has extensive experience in assisting chemical and healthcare companies in all aspects of their IP portfolios in marketplaces across the Asia-Pacific. Our ability to deliver high quality IP services to the chemical and healthcare sectors is enhanced by our Chemical / Life Sciences patent team comprised of scientists trained in a broad range of relevant technologies including cardiovascular, immunoscience, metabolics, neuroscience, oncology and virology. Their expertise includes patent term extensions, data exclusivity, regulatory approval and all other aspects of advice relating to our client’s core commercial products.
Our trade marks team has a long history of representing chemical and healthcare companies in trade mark matters. Our professionals have a deep understanding of the potential issues of trade mark registration of chemical and healthcare brands across the Asia-Pacific. Our dedicated trade mark searching team has experience in pharmaceutical trade mark searches and regularly conduct direct searches of relevant name and image databases.
Spruson & Ferguson Lawyers regularly advises on a wide variety of matters, from general advertising and promotion regulation to consumer protection law, as well as advice on specific biopharma industry codes of conduct and applicable biopharma legislation. Our patent litigation team has an outstanding reputation in the enforcement of IP rights and has acted in some of the most keenly contested patent cases in Australia.
Kristian Robinson is the Managing Director of Spruson & Ferguson (Asia). Kristian is based in the Singapore head office of our Asian hub.
Kristian has considerable experience in patent practice…
Kristian Robinson is the Managing Director of Spruson & Ferguson (Asia). Kristian is based in the Singapore head office…
Oliver Lutze is Spruson & Ferguson’s Country Manager for China. He is based in Beijing and advises on patent matters with a special focus on China activities.
Oliver’s practice primarily…
Oliver Lutze is Spruson & Ferguson’s Country Manager for China. He is based in Beijing and advises on patent…
Simon is an experienced patent attorney specialising in biotechnology. As head of Spruson & Ferguson’s Chemical/Life Sciences team in Australia, he assists clients in all aspects of patent practice…
Simon is an experienced patent attorney specialising in biotechnology. As head of Spruson & Ferguson’s Chemical/Life Sciences team in…
In two appeal judgements handed down concurrently on 18 March 2022, the Full Federal Court has clarified that a pharmaceutical patent term extension (PTE) for a patent should be…
In two appeal judgements handed down concurrently on 18 March 2022, the Full Federal Court has clarified that a…
According to the Philippines Intellectual Property Code, the following in relation to pharmaceutical substances are not patent eligible and do not possess inventive step:
the mere discovery of a new…
According to the Philippines Intellectual Property Code, the following in relation to pharmaceutical substances are not patent eligible and…
In Merck Sharp & Dohme Corp. v Sandoz Pty Ltd FCA 947, the Federal Court of Australia has determined that a pharmaceutical patent term extension (PTE) for a…
In Merck Sharp & Dohme Corp. v Sandoz Pty Ltd FCA 947, the Federal Court of Australia has…
